Withdrawing and withholding life-sustaining treatments in Japan
-
- MIZUNO Toshinari
- 東京大学大学院医学系研究科生命・医療人材養成ユニット
-
- YOKONO Megumi
- 早稲田大学社会科学総合学術院
Bibliographic Information
- Other Title
-
- 日本における生命維持治療の中止と差控え
Search this article
Abstract
According to the policy statements of professional medical societies in the US and UK, as well as prominent American and English bioethicists, there are no morally relevant differences between withdrawing and withholding life-sustaining treatments. Both withdrawing and withholding life-sustaining treatments are permitted in the US and UK and decisions to initiate either procedure are held to the same criteria in both countries. Leading Japanese bioethicists also support this view. However, due to Japan's unique cultural and institutional backgrounds, terminally ill patients, their family, and medical practitioners would suffer from a disproportionate amount of psychological burden if the withdrawal of life-sustaining treatments were held to the same conditions as withholding treatment, as is commonly done in the US. To prevent such undesirable results, even if we were to recognize no morally relevant differences between withdrawing and withholding life-sustaining treatments, we argue that the decision to withdraw or withhold such treatments can be justified on different conditions in Japan.
Journal
-
- Bioethics
-
Bioethics 16 (1), 84-90, 2006
Japan Association for Bioethics
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679459353984
-
- NII Article ID
- 110006858333
-
- NII Book ID
- AN10355291
-
- ISSN
- 2189695X
- 13434063
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
- KAKEN
- Crossref
-
- Abstract License Flag
- Disallowed